CNCR vs. MDEV
Compare and contrast key facts about Loncar Cancer Immunotherapy ETF (CNCR) and First Trust Indxx Medical Devices ETF (MDEV).
CNCR and MDEV are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. CNCR is a passively managed fund by Exchange Traded Concepts that tracks the performance of the Loncar Cancer Immunotherapy Index. It was launched on Oct 13, 2015. MDEV is a passively managed fund by First Trust that tracks the performance of the Indxx Global Medical Equipment Index. It was launched on Jun 22, 2021. Both CNCR and MDEV are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Performance
CNCR vs. MDEV - Performance Comparison
Loading graphics...
CNCR vs. MDEV - Yearly Performance Comparison
| 2026 (YTD) | |
|---|---|
CNCR Loncar Cancer Immunotherapy ETF | 0.00% |
MDEV First Trust Indxx Medical Devices ETF | -8.44% |
Returns By Period
CNCR
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
MDEV
- 1D
- -0.39%
- 1M
- -6.21%
- YTD
- -9.27%
- 6M
- -6.77%
- 1Y
- -5.20%
- 3Y*
- -2.14%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
CNCR vs. MDEV - Expense Ratio Comparison
CNCR has a 0.79% expense ratio, which is higher than MDEV's 0.70% expense ratio.
Return for Risk
CNCR vs. MDEV — Risk / Return Rank
CNCR
MDEV
CNCR vs. MDEV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loncar Cancer Immunotherapy ETF (CNCR) and First Trust Indxx Medical Devices ETF (MDEV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading graphics...
Sharpe Ratios by Period
| CNCR | MDEV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | -0.28 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | -0.30 | — |
Dividends
CNCR vs. MDEV - Dividend Comparison
Neither CNCR nor MDEV has paid dividends to shareholders.
Drawdowns
CNCR vs. MDEV - Drawdown Comparison
The maximum CNCR drawdown since its inception was 0.00%, smaller than the maximum MDEV drawdown of -42.34%. Use the drawdown chart below to compare losses from any high point for CNCR and MDEV.
Loading graphics...
Drawdown Indicators
| CNCR | MDEV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | 0.00% | -42.34% | +42.34% |
Max Drawdown (1Y)Largest decline over 1 year | — | -14.88% | — |
Current DrawdownCurrent decline from peak | 0.00% | -32.10% | +32.10% |
Average DrawdownAverage peak-to-trough decline | 0.00% | -25.40% | +25.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 4.77% | — |
Volatility
CNCR vs. MDEV - Volatility Comparison
Loading graphics...
Volatility by Period
| CNCR | MDEV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 5.59% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 10.69% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 0.00% | 18.98% | -18.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 0.00% | 18.98% | -18.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 0.00% | 18.98% | -18.98% |